Published November 5, 2004 | Version v1
Journal article

N-Formylated humanin activates both formyl peptide receptor-like 1 and 2

  • 1. Discovery Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., 10 Wadai, Tsukuba, Ibaraki 300-4293 (Japan)

Description

We have discovered that humanin (HN) acts as a ligand for formyl peptide receptor-like 1 (FPRL1) and 2 (FPRL2). This discovery was based on our finding that HN suppressed forskolin-induced cAMP production in Chinese hamster ovary (CHO) cells expressing human FPRL1 (CHO-hFPRL1) or human FPRL2 (CHO-hFPRL2). In addition, we found that N-formylated HN (fHN) performed more potently as a ligand for FPRL1 than HN: in CHO-hFPRL1 cells, the effective concentration for the half-maximal response (EC50) value of HN was 3.5 nM, while that of fHN was 0.012 nM. We demonstrated by binding experiments using [125I]-W peptide that HN and fHN directly interacted with hFPRL1 on the membrane. In addition, we found that HN and fHN showed strong chemotactic activity for CHO-hFPRL1 and CHO-hFPRL2 cells. HN is known to have a protective effect against neuronal cell death. Our findings contribute to the understanding of the mechanism behind HN's function

Additional details

Identifiers

DOI
10.1016/j.bbrc.2004.09.046;
PII
S0006-291X(04)02041-8;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
324
Journal Issue
1
Journal Page Range
p. 255-261
ISSN
0006-291X
CODEN
BBRCA9

Optional Information

Copyright
Copyright (c) 2004 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.